Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tdap Immunization in Pregnancy for Neonatal Pertussis Protection
NCT00553228Phase 3Completed
- Start
- Nov 2007
- Primary completion
- Dec 2015
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 3, randomised trial of tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine in pertussis (2 arms). Primary endpoint: Comparison of serum IgG antibody levels against PT, FHA, PRN, FIM at 13 months. Started Nov 2007; status: completed.
02
Drugs
tetanus toxoid + reduced diphtheria toxoid + acellular pertussis vaccine
03
Conditions
pertussis
Beyond the preview
Go deeper on NCT00553228.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00553228.